Ongoing Special Issue
Engage with focused collections in thyroid cancer.
Journal at a Glance
ISSN: 2574-4496
DOI Prefix: 10.14302/issn.2574-4496
License: CC BY 4.0
Peer reviewed open access journal
Scope Alignment
Thyroid carcinoma, endocrine oncology, surgical and medical management, molecular diagnostics, and survivorship care. We prioritize evidence that improves diagnosis and outcomes.
Publishing Model
Open access, single blind peer review, and rapid publication after acceptance and production checks. Metadata validation and DOI registration are included.
JTC features ongoing special issues that highlight timely topics in thyroid cancer research. These collections bring together leading researchers to accelerate discovery and translation into clinical practice.
- Review the current special issue themes
- Ensure your manuscript aligns with the stated scope
- Submit through ManuscriptZone with the correct issue selection
- Engage with guest editor feedback during review
Focused Visibility
Highlight urgent clinical questions.
Collaborative Networks
Connect with multi center teams.
Clinical Impact
Translate evidence into care pathways.
Open Access
Immediate access for global stakeholders.
Guest editors curate thematic content and ensure rigorous peer review. They collaborate with the editorial office to maintain consistent standards and timelines.
| Stage | Timing | Notes |
|---|---|---|
| Call Open | 6 to 12 weeks | Submission window varies by theme |
| Peer Review | 09 days | Single blind review |
| Revision | 3 to 5 days | Targeted responses to reviewers |
| Publication | 3 days | After acceptance and production |
- Targeted therapy and resistance
- Surgical outcomes and lymph node management
- Radioactive iodine strategies
- Molecular diagnostics and biomarkers
- Survivorship and quality of life
- Pediatric thyroid cancer
- Define the thyroid cancer research gap the special issue addresses.
- Provide a rationale for guest editor expertise and topic coverage.
- Specify anticipated article types and approximate submission volume.
- Outline peer review timelines and editorial decision workflows.
- Describe outreach plans to endocrine oncology and surgical societies.
- Identify data reporting standards required for submissions.
- Clarify whether cross disciplinary submissions are in scope.
- List any planned invited contributions or consortium partners.
- Provide proposed metrics for impact or clinical relevance.
- Describe data harmonization requirements for multicenter submissions.
- Specify expected submission window and targeted publication date.
- Note any regulatory or guideline considerations for topic areas.
- Specify how guest editors will manage conflicts of interest.
- Outline plans for an editorial introduction or synthesis article.
- Describe collaboration with registries or clinical networks.
- Provide criteria for invited versus open submissions.
- Include data reporting checklists for imaging or molecular studies.
- State plans for dissemination to clinical stakeholders.
- Describe plans for consensus statements or clinical guidelines.
- Include expectations for molecular data reporting consistency.
- Outline strategies to recruit multidisciplinary contributors.
- Provide plans for patient centered outcomes reporting.
- Specify whether imaging datasets will be shared.
- Describe integration with ongoing clinical trials or registries.
- Outline dissemination plans for clinical audiences.
- Describe expectations for systematic review contributions.
- Provide plans for imaging standardization across sites.
- Clarify expectations for genomic data deposition.
- Describe strategies for harmonizing staging criteria.
- Outline editorial plans for companion reviews or commentaries.
- Specify patient advocacy or survivorship perspectives if applicable.
Where can I see current themes?
Current themes are listed on this page and updated regularly.
Do special issues use the same review process?
Yes. All papers follow JTC peer review standards.
Can I propose a new theme?
Yes. Send proposals to [email protected].
JTC is committed to rigorous, transparent publishing in thyroid cancer research and care. We emphasize reproducible clinical methods, clear reporting of diagnostic criteria, and ethical compliance across all article types.
The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].
We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in endocrine oncology, surgical outcomes, and translational thyroid research.
Explore Ongoing Special Issues
Find an active theme aligned with your thyroid cancer research.